Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. (哈药股份) announced that its subsidiary, Harbin Pharmaceutical Group Pharmaceutical Factory (哈药总厂), received approval from the National Medical Products Administration for two formulations of injectable cefoperazone sodium and sulbactam sodium, indicating successful completion of the consistency evaluation for generic drug quality and efficacy [1] Group 1 - The company received approval for two formulations: injectable cefoperazone sodium and sulbactam sodium in two ratios (1:1 and 2:1) [1] - A total of four specifications for these drugs have passed the consistency evaluation [1]

Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. (哈药股份) has received approval from the National Medical Products Administration for two formulations of injectable cefoperazone sodium and sulbactam sodium, indicating a significant advancement in its product portfolio and compliance with quality and efficacy standards for generic drugs [1] Group 1 - The company’s subsidiary, Harbin Pharmaceutical Group Pharmaceutical Factory, has been granted a "Drug Supplement Application Approval Notice" for two formulations of injectable cefoperazone sodium and sulbactam sodium [1] - The approved products include four specifications that have passed the consistency evaluation of quality and efficacy for generic drugs [1]